CFRA has a "buy" rating and $1,040 price target for ... medical device and consumer health care products industries. Its key products include anti-inflammation drug Stelara, multiple myeloma ...

Best Buy is partnering with a large U.S. healthcare system to develop “new hospital at home offerings,” pushing deeper into developing new healthcare services and products. “The goal of the ...

Best Buy will soon begin carrying continuous glucose monitoring devices that require a prescription, opening the door to broader future healthcare product offerings ordered by physicians for their ...

Huckman, Robert S., Rosabeth Moss Kanter, Antonio Moreno, Bradley Staats, and Sarah Mehta. "Best Buy Health: Enabling Care at Home." Harvard Business School Case 624-009, February 2024. (Revised ...

Argus has a "buy" rating and $45 price target for GSK stock, which closed at $39.13 on Oct. 14. Perrigo provides self-care products and over-the-counter health and wellness solutions. In 2023 ...